SEARCH OUR PRODUCT CATALOG

THRA-B4GALNT2 Fusion FISH Probe

The THRA-B4GALNT2 Fusion FISH Probe is used to confirm a fusion of the THRA and B4GALNT2 genes. The fusion of the THRA and B4GALNT2 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.

** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.

Turnaround Time: 7-10 Business Days    Shipping Time: 1-2 Day Expedited Shipping

SKU Test Kits Buffer Dye Color Order Now
THRA-B4GALNT2-20-ORGR  (Standard Design) 20 (40 μL) 200 μL
THRA-B4GALNT2-20-RERE 20 (40 μL) 200 μL
THRA-B4GALNT2-20-REOR 20 (40 μL) 200 μL
THRA-B4GALNT2-20-REGO 20 (40 μL) 200 μL
THRA-B4GALNT2-20-REGR 20 (40 μL) 200 μL
THRA-B4GALNT2-20-REAQ 20 (40 μL) 200 μL
THRA-B4GALNT2-20-ORRE 20 (40 μL) 200 μL
THRA-B4GALNT2-20-OROR 20 (40 μL) 200 μL
THRA-B4GALNT2-20-ORGO 20 (40 μL) 200 μL
THRA-B4GALNT2-20-ORAQ 20 (40 μL) 200 μL
THRA-B4GALNT2-20-GORE 20 (40 μL) 200 μL
THRA-B4GALNT2-20-GOOR 20 (40 μL) 200 μL
THRA-B4GALNT2-20-GOGO 20 (40 μL) 200 μL
THRA-B4GALNT2-20-GOGR 20 (40 μL) 200 μL
THRA-B4GALNT2-20-GOAQ 20 (40 μL) 200 μL
THRA-B4GALNT2-20-GRRE 20 (40 μL) 200 μL
THRA-B4GALNT2-20-GROR 20 (40 μL) 200 μL
THRA-B4GALNT2-20-GRGO 20 (40 μL) 200 μL
THRA-B4GALNT2-20-GRGR 20 (40 μL) 200 μL
THRA-B4GALNT2-20-GRAQ 20 (40 μL) 200 μL
THRA-B4GALNT2-20-AQRE 20 (40 μL) 200 μL
THRA-B4GALNT2-20-AQOR 20 (40 μL) 200 μL
THRA-B4GALNT2-20-AQGO 20 (40 μL) 200 μL
THRA-B4GALNT2-20-AQGR 20 (40 μL) 200 μL
THRA-B4GALNT2-20-AQAQ 20 (40 μL) 200 μL

THRA Gene Summary

The protein encoded by this gene is a nuclear hormone receptor for triiodothyronine. It is one of the several receptors for thyroid hormone, and has been shown to mediate the biological activities of thyroid hormone. Knockout studies in mice suggest that the different receptors, while having certain extent of redundancy, may mediate different functions of thyroid hormone. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]

Gene Name: Thyroid Hormone Receptor, Alpha

Chromosome: CHR17: 38218445 -38250120

Locus: 17q21.1

B4GALNT2 Gene Summary

B4GALNT2 catalyzes the last step in the biosynthesis of the human Sd(a) antigen through the addition of an N-acetylgalactosamine residue via a beta-1,4 linkage to a subterminal galactose residue substituted with an alpha-2,3-linked sialic acid. B4GALNT2 also catalyzes the last step in the biosynthesis of the Cad antigen (Montiel et al., 2003 [PubMed 12678917]).[supplied by OMIM, Mar 2008]

Gene Name: Beta-1,4-N-acetyl-galactosaminyltransferase 2

Chromosome: CHR17: 47209821 -47247351

Locus: 17q21.32

Gene Diseases

The THRA B4GALNT2 Fusion has been associated with the following diseases:

Disease Name
Breast Invasive Carcinoma

FISH Probe Protocols

Protocol, Procedure, or Form Name Last Modified Download

Customer Publications

There are currently no FISH related publications for this probe.